The increasing prevalence of kidney failure and end-stage renal disease, along with a growing incidence of risk factors like ...

Outset Medical (Nasdaq: OM) announced today that the FDA says it addressed all issues cited in a 2023 warning letter.

IN A major win for dialysis patients, the Philippine Health Insurance Corp. (PhilHealth) has significantly enhanced its Z ...

The Philippine Health Insurance Corporation (PhilHealth) has expanded the Z Benefit package for Peritoneal Dialysis (PD) with a rate reaching almost PH ...

This approach is claimed to improve organ recovery and potentially eliminate future renal replacement therapy (RRT) requirements, including dialysis. The SCD has also gained FDA breakthrough device ...

IN line with President Ferdinand Marcos, Jr.'s assurance of continuous expansion in health care benefits despite zero subsidy ...

The global dialysis equipment market is on a strong growth trajectory, with projected sales expected to increase from USD 11,126.0 million in 2024 to an impressive USD 17,780.9 million by 2034. This ...

either by a conservative approach or the most appropriate renal replacement therapy (RRT) modality (kidney transplantation, hemodialysis or peritoneal dialysis), will have a major impact on ...

The global continuous renal replacement therapy market is set for significant expansion, with projections indicating a surge ...

Pediatric patients can receive P510,000 to P765,210 for CAPD and P763,000 to P1.2 million for APD. The package also includes coverage for related services like infection prevention and treatment for ...

We are delighted that QUELIMMUNE is now available to treat severely ill children at yet another prominent academic medical center,” said Tim Varacek, SeaStar Medical Senior Vice President, Commercial ...